Jackson Thornton Asset Management »

Sarepta Therapeutics shares owned by Jackson Thornton Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Jackson Thornton Asset Management from 13F filings

Historical chart of Jackson Thornton Asset Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Jackson Thornton Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Jackson Thornton Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $212k 9.5k 22.35

More positions owned by Jackson Thornton Asset Management

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
American Centy Etf Tr Intl Smcp Vlu (AVDV)

View all positions for Jackson Thornton Asset Management

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Standard Life Aberdeen
Two Sigma Investments
D. E. Shaw & Co
UBS Group
First Trust Advisors
Two Sigma Advisers
Geode Capital Management
LMR Partners
Citadel Advisors
AQR Capital Management

View all funds holding Sarepta Therapeutics